Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...

Expanding the long-running partnership will bring Medtronic technologies, such as its Nellcor pulse oximetry product, to more ...

On June 21, Covidien plc ( COV), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO 2 single parameter module in North America, European Economic Area (EEA) ...

- Nellcor™ Pulse Oximetry Technology Demonstrated Statistically Significant Difference in Time to Deliver a Stable Oxygen Saturation Value and Heart Rate According to the study, a stable signal was ...

BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...

DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...

“Clinicians can feel confident using the Nellcor Portable SpO 2 Patient Monitoring System for these important patient assesments,” said Dr. Scott Kelley, chief medical officer, Respiratory and ...

Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...

On June 21, Covidien plc (COV), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO 2 single parameter module in North America, European Economic Area (EEA) ...

DUBLIN, Feb. 9, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the results of an independent, prospective observational study comparing the efficacy ...